The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improved prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma.
 
Guru Sonpavde
No Relationships to Disclose
 
Gregory Russell Pond
No Relationships to Disclose
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Oncogenex; Onyx
 
Dean F. Bajorin
No Relationships to Disclose
 
Ashley Marie Regazzi
No Relationships to Disclose
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Stephanie A. Mullane
No Relationships to Disclose
 
Guenter Niegisch
No Relationships to Disclose
 
Peter Albers
Honoraria - Dendreon; Hexal; Janssen Oncology; Myriad Genetics; Sandoz; Sanofi
Consulting or Advisory Role - Myriad Genetics; Sanofi
 
Andrea Necchi
No Relationships to Disclose
 
Giuseppe di Lorenzo
No Relationships to Disclose
 
Ronan Fougeray
Employment - Pierre Fabre
 
Matt D. Galsky
Stock and Other Ownership Interests - Dual Therapeutics
Consulting or Advisory Role - Astellas Pharma; BioMotiv; Dendreon; GlaxoSmithKline; Janssen; Lilly; Merck
Research Funding - Bristol-Myers Squibb (Inst); Dendreon (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
Travel, Accommodations, Expenses - Astellas Pharma; BioMotiv; Dendreon; Merck
 
Srikala S. Sridhar
No Relationships to Disclose
 
Yoo-Joung Ko
No Relationships to Disclose
 
Matthew I. Milowsky
Research Funding - Astellas Pharma (Inst); BIND Therapeutics (Inst); Dendreon (Inst); Exelixis (Inst); Johnson & Johnson (Inst)
 
Joaquim Bellmunt
No Relationships to Disclose